Tailored Medicine: Pharmogenomics and Pharmacogenetics
References
1. Sim SC, Altman RB, Ingelman-Sundberg M. Databases in the area of pharmacogenetics. Hum Mutat. 2011;32:526-31.
2. Oetting WS. Clinical genetics & human genome variation: the 2008 Human Genome Variation Society scientific meeting. Hum Mutat. 2009;30:852-6.
3. Pinto N, Dolan ME. Clinically relevant genetic variations in drug metabolizing enzymes. Curr Drug Metab. 2011;12:487-97.
4. Boone PM, Wiszniewski W, Lupski JR. Genomic medicine and neurological disease. Hum Genet. 2011 [Epub ahead of print].
5. Johansson I, Ingelman-Sundberg M. Genetic polymorphism and toxicology-with emphasis on cytochrome p450. Toxicol Sci. 2011;120:1-13.
6. Searle R, Hopkins PM. Pharmacogenomic variability and anaesthesia. Br J Anaesth. 2009;103:14-25.
7. Restrepo JG, García-Martín E, Martínez C, et al. Polymorphic drug metabolism in anaesthesia. Curr Drug Metab. 2009;10:236-46.
8. Carlquist JF, Anderson JL. Pharmacogenetic mechanisms underlying unanticipated drug responses. Discov Med. 2011;11:469-78.
9. Gómez A, Ingelman-Sundberg M. Pharmacoepigenetics: its role in interindividual differences in drug response. Clin Pharmacol Ther. 2009;85:426-30.
10. Baer-Dubowska W, Majchrzak-Celinska A, Cichocki M. Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs. Pharmacol Rep. 2011;63:293-304.
11. Martín-Subero JI, Esteller M. Profiling epigenetic alterations in disease. Adv Exp Med Biol. 2011;711: 162-77.
12. Searle R, Hopkins PM. Pharmacogenomic variability and anaesthesia. Br J Anaesth. 2009;103:14-25.
13. Restrepo JG, García-Martín E, Martínez C, et al. Polymorphic drug metabolism in anaesthesia. Curr Drug Metab. 2009;10:236-46.
2. Oetting WS. Clinical genetics & human genome variation: the 2008 Human Genome Variation Society scientific meeting. Hum Mutat. 2009;30:852-6.
3. Pinto N, Dolan ME. Clinically relevant genetic variations in drug metabolizing enzymes. Curr Drug Metab. 2011;12:487-97.
4. Boone PM, Wiszniewski W, Lupski JR. Genomic medicine and neurological disease. Hum Genet. 2011 [Epub ahead of print].
5. Johansson I, Ingelman-Sundberg M. Genetic polymorphism and toxicology-with emphasis on cytochrome p450. Toxicol Sci. 2011;120:1-13.
6. Searle R, Hopkins PM. Pharmacogenomic variability and anaesthesia. Br J Anaesth. 2009;103:14-25.
7. Restrepo JG, García-Martín E, Martínez C, et al. Polymorphic drug metabolism in anaesthesia. Curr Drug Metab. 2009;10:236-46.
8. Carlquist JF, Anderson JL. Pharmacogenetic mechanisms underlying unanticipated drug responses. Discov Med. 2011;11:469-78.
9. Gómez A, Ingelman-Sundberg M. Pharmacoepigenetics: its role in interindividual differences in drug response. Clin Pharmacol Ther. 2009;85:426-30.
10. Baer-Dubowska W, Majchrzak-Celinska A, Cichocki M. Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs. Pharmacol Rep. 2011;63:293-304.
11. Martín-Subero JI, Esteller M. Profiling epigenetic alterations in disease. Adv Exp Med Biol. 2011;711: 162-77.
12. Searle R, Hopkins PM. Pharmacogenomic variability and anaesthesia. Br J Anaesth. 2009;103:14-25.
13. Restrepo JG, García-Martín E, Martínez C, et al. Polymorphic drug metabolism in anaesthesia. Curr Drug Metab. 2009;10:236-46.
How to Cite
1.
B. Bravo S, Caminos JE, Eslava Schmalbach JH. Tailored Medicine: Pharmogenomics and Pharmacogenetics. Colomb. J. Anesthesiol. [Internet]. 2011 Jul. 1 [cited 2024 Apr. 29];39(3):308-13. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/837
Downloads
Download data is not yet available.
Published
2011-07-01
How to Cite
1.
B. Bravo S, Caminos JE, Eslava Schmalbach JH. Tailored Medicine: Pharmogenomics and Pharmacogenetics. Colomb. J. Anesthesiol. [Internet]. 2011 Jul. 1 [cited 2024 Apr. 29];39(3):308-13. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/837
Issue
Section
Editorial
Altmetric
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
